Drug Profile
Calcipotriol topical spray - Cerbios Pharma/Lipidor
Alternative Names: AKP01; AKVANO®/calcipotriolLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Cerbios-Pharma; Lipidor
- Developer Cadila Pharmaceuticals; Lipidor
- Class Antipsoriatics; Cyclohexanes; Cyclopropanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Psoriasis
Most Recent Events
- 01 Jul 2021 Lipidor completes a phase III trial in Psoriasis (Topical, Spray) before July 2021
- 01 Jul 2021 Lipidor enters into an licence agreement with RELIFE-Srl and grants rights to register, promote, distribute, and market Calcipotriol for Psoriasis in the EU, Turkey, in the UK, Switzerland, CIS, and Balkan countries
- 04 Mar 2021 Phase III development for psoriasis is ongoing in India